在2型糖尿病患者中,动脉硬性斑块的药理学回归
Loredana Bucciarelli1, Daniele Andreini2, Giulio Stefanini3
1Pio Albergo Trivulzio, Italy; International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di scienze Biomediche e Cliniche, Università di Milano, Italy.
动脉样硬化回归在人类是可能的,挑战了几十年的信念. 结合药物来管理高血糖症,脂质不良症和炎症可能会加速2型糖尿病患者的斑块回归.
科学领域:
- 心血管医学 心血管医学
- 医学研究 医学研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化是全球主要的健康问题,急性冠状动脉综合征导致显著的死亡率.
- 斑块破裂,通常是由于机械压力 (帽子疲劳),导致急性冠状动脉综合征.
- 易受伤害的斑块具有柔软的核心,薄纤维状盖,受到炎症和高胆固醇血症的影响.
研究的目的:
- 在临床前和临床研究中审查动脉样硬化回归的证据.
- 探索用于斑块回归的机制性见解和药理学药剂.
- 专注于回归策略,特别是对于2型糖尿病患者.
主要方法:
- 审查关于动脉样硬化回归现有的临床前和临床研究.
- 对斑块回归过程的机制性见解的分析.
- 对针对高血糖,血脂不良和炎症的药理学药物的评估.
主要成果:
- 动脉样硬化回归,曾经怀疑,现在得到了新兴证据的支持.
- 先进的斑块成分,如死亡,化和纤维化,对回归构成挑战.
- 新的动物模型和成像技术可以更好地对斑块体积进行定量评估.
结论:
- 动脉样硬化回归是可以实现的,需要进一步研究.
- 针对高血糖,脱脂症和炎症的组合疗法可能会促进斑块回归.
- 药理回归策略对2型糖尿病患者尤其有希望.
更多相关视频
09:14The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
Published on: October 3, 2017
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
相关概念视频
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
